Form 4: RxSight Executive Receives Stock Grant
Insider Transaction (Form 4)
Ronald M Kurtz, Chief Medical Officer of RxSight, Inc., reported multiple transactions in common stock on September 5, 2026.
Summary
- Disposition to the issuer: disposed of 338,819 Stock option (right to buy) on September 5, 2026 (Direct).
- Disposition to the issuer: disposed of 200,000 Stock Option (right to buy) on September 5, 2026 (Direct).
- Disposition to the issuer: disposed of 149,000 Stock Option (right to buy) on September 5, 2026 (Direct).
- Disposition to the issuer: disposed of 215,000 Stock Option (right to buy) on September 5, 2026 (Direct).
- Grant/award: acquired 254,751 Stock Option (right to buy) on September 5, 2026; holds 254,751 after (Direct).
- Grant/award: acquired 173,913 Stock Option (right to buy) on September 5, 2026; holds 173,913 after (Direct).
- Grant/award: acquired 96,129 Stock Option (right to buy) on September 5, 2026; holds 96,129 after (Direct).
- Grant/award: acquired 161,654 Stock Option (right to buy) on September 5, 2026; holds 161,654 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ronald M Kurtz — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Disposition to the issuer | Stock option (right to buy) | 338,819 | — | — | 0 |
| 2026-09-05 | Disposition to the issuer | Stock Option (right to buy) | 200,000 | — | — | 0 |
| 2026-09-05 | Disposition to the issuer | Stock Option (right to buy) | 149,000 | — | — | 0 |
| 2026-09-05 | Disposition to the issuer | Stock Option (right to buy) | 215,000 | — | — | 0 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 254,751 | — | — | 254,751 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 173,913 | — | — | 173,913 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 96,129 | — | — | 96,129 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 161,654 | — | — | 161,654 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Disposition to the issuer (338,819 shares) |
| 2026-09-05 | Disposition to the issuer (200,000 shares) |
| 2026-09-05 | Disposition to the issuer (149,000 shares) |
| 2026-09-05 | Disposition to the issuer (215,000 shares) |
| 2026-09-05 | Grant/award (254,751 shares) |
| 2026-09-05 | Grant/award (173,913 shares) |
| 2026-09-05 | Grant/award (96,129 shares) |
| 2026-09-05 | Grant/award (161,654 shares) |
Keywords
insider transaction, Form 4, RXST, RxSight, Inc., neutral, Ronald M Kurtz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.